Testing specimens for Chlamydia trachomatis.
The introduction of NAATs has revolutionised chlamydial diagnostics and these tests are now the standard of care. However, as with all new technologies, they have also presented new challenges. This review attempts to answer some of the questions that have been raised, particularly by groups about to embark on implementing a screening programme. Laboratory tests are continually changing but it is hoped that the paper provides a useful update of the current situation.
Skidmore
S
S
Department of Microbiology, Princess Royal Hospital, Telford TF1 6TF, UK. sue.skidmore@rsh.nhs.uk
Horner
P
P
Mallinson
H
H
D002690:Chlamydia Infections / Q000175:diagnosis*; D002692:Chlamydia trachomatis; D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000592:standards; D016133:Polymerase Chain Reaction / Q000592:standards; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D013048:Specimen Handling